Alnylam Pharmaceuticals
ALNY
#546
Rank
HK$350.23 B
Marketcap
HK$2,651
Share price
-2.14%
Change (1 day)
24.17%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company